Download | < Back |
10 Aug 2021 | |
Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of Genomic Valley Biotech Limited ('Company') in its meeting held today approved the Un-Audited Financial Results (Standalone) for the Quarter and three months ended 30th June, 2021 of the Company as per Indian Accounting Standards (IND-AS) along with the Limited Review Report. Copy of the results along with the Limited Review Report of Statutory Auditors is attached herewith for your perusal.<BR> <BR> The above information will also be available on the Company's Website, www.genomicvalley.com .<BR> <BR> The meeting of the Board of Directors commenced on 11:45 A.M. and concluded at 04:00 P.M.<BR> | |
View all announcements for Genomic Valley Biotech Ltd | Source: BSE India |